Aaron Cowen’s Regenxbio RGNX Stock Holding History

Aaron Cowen’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,820	Closed	-$674K	–	100
2020 Q1	$674K	Buy	+20,820	New	+$867K	0.02%	56

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aaron Cowen's RGNX Position: Q2 2020 in Review

Aaron Cowen sold out of Regenxbio (RGNX) in Q2 2020, closing a stake of 20,820 shares — an estimated $674K sold.

Aaron Cowen first reported a position in RGNX in Q1 2020 and held it in 1 quarter. The position peaked at $674K in Q1 2020. 179 funds tracked by Wall St. Rank hold RGNX as of Q2 2020.

Aaron Cowen reported no remaining Regenxbio position as of Q2 2020 after selling out during the quarter.
Aaron Cowen sold 20,820 Regenxbio shares in Q2 2020, an estimated $674K.
Aaron Cowen first reported a position in Regenxbio in Q1 2020 and held it in 1 quarter.
Aaron Cowen's Regenxbio position peaked at $674K in Q1 2020.
179 funds tracked by Wall St. Rank held Regenxbio as of Q2 2020.

Based on Suvretta Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.